Rhumbline Advisers Increases Stake in Avantor, Inc. (NYSE:AVTR)

Rhumbline Advisers grew its position in Avantor, Inc. (NYSE:AVTR) by 1.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,922,368 shares of the company’s stock after buying an additional 33,692 shares during the period. Rhumbline Advisers owned approximately 0.28% of Avantor worth $40,504,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Creative Planning lifted its position in Avantor by 54.0% in the 3rd quarter. Creative Planning now owns 28,136 shares of the company’s stock valued at $728,000 after acquiring an additional 9,866 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Avantor by 414.5% during the third quarter. Blue Trust Inc. now owns 7,547 shares of the company’s stock valued at $195,000 after buying an additional 6,080 shares during the last quarter. Castleview Partners LLC increased its holdings in Avantor by 35.6% in the 3rd quarter. Castleview Partners LLC now owns 17,514 shares of the company’s stock worth $453,000 after buying an additional 4,599 shares in the last quarter. Whittier Trust Co. increased its holdings in Avantor by 4.7% in the 3rd quarter. Whittier Trust Co. now owns 209,036 shares of the company’s stock worth $5,405,000 after buying an additional 9,321 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its position in Avantor by 3.1% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 104,438 shares of the company’s stock worth $2,701,000 after buying an additional 3,179 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Trading Down 1.3 %

Shares of AVTR stock opened at $17.87 on Tuesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The stock has a fifty day simple moving average of $21.44 and a two-hundred day simple moving average of $23.20. The firm has a market capitalization of $12.16 billion, a PE ratio of 38.84, a PEG ratio of 3.87 and a beta of 1.28. Avantor, Inc. has a 52-week low of $17.83 and a 52-week high of $28.00.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same quarter in the previous year, the company earned $0.22 earnings per share. On average, analysts predict that Avantor, Inc. will post 0.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of research analyst reports. Robert W. Baird lowered their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Morgan Stanley lowered their price target on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Barclays lowered their target price on Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Raymond James restated an “outperform” rating and set a $24.00 price target (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Finally, Stifel Nicolaus cut their target price on shares of Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Monday, February 10th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, Avantor has a consensus rating of “Moderate Buy” and a consensus price target of $25.92.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.